A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
2014 · Biological Psychiatry · 474 citations
https://doi.org/10.1016/j.biopsych.2014.03.026
J
Jess W. Brallier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
1.6K
Citations
13
h-index
17
i10-index
Jess W. Brallier is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Treatment of Major Depression & Tryptophan and brain disorders & Cardiac, Anesthesia and Surgical Outcomes. The author has an h-index of 13, co-authored 23 publications.
ORCID: 0000-0002-5243-8237Papers by this author
worksKetamine for rapid reduction of suicidal ideation: a randomized controlled trial
2015 · Psychological Medicine · 291 citations
https://doi.org/10.1017/s0033291715001506
Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial
2014 · Neuropsychopharmacology · 134 citations
https://doi.org/10.1038/npp.2014.298
Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial
2019 · Neuropsychopharmacology · 50 citations
https://doi.org/10.1038/s41386-019-0365-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat